Myron S. Czuczman,on behalf of the 405 Study Investigators,Luis Fayad,on behalf of the 405 Study Investigators,Vincent Delwail,on behalf of the 405 Study Investigators,Guillaume Cartron,on behalf of the 405 Study Investigators,Eric Jacobsen,on behalf of the 405 Study Investigators,Kazimierz Kuliczkowski,on behalf of the 405 Study Investigators,Brian K. Link,on behalf of the 405 Study Investigators,Lauren Pinter-Brown,on behalf of the 405 Study Investigators,John Radford,on behalf of the 405 Study Investigators,Andrzej Hellmann,on behalf of the 405 Study Investigators,Eve Gallop-Evans,on behalf of the 405 Study Investigators,Christine G. DiRienzo,on behalf of the 405 Study Investigators,Nancy Goldstein,on behalf of the 405 Study Investigators,Ira Gupta,on behalf of the 405 Study Investigators,Roxanne C. Jewell,on behalf of the 405 Study Investigators,Thomas S. Lin,on behalf of the 405 Study Investigators,Steen Lisby,on behalf of the 405 Study Investigators,Martin Schultz,on behalf of the 405 Study Investigators,Charlotte A. Russell,on behalf of the 405 Study Investigators,Anton Hagenbeek,on behalf of the 405 Study Investigators

View Articletitled, Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study

Supplemental data

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

Karen E. Deffenbacher,Javeed Iqbal,Warren Sanger,Yulei Shen,Cynthia Lachel,Zhongfeng Liu,Yanyan Liu,Megan S. Lim,Sherrie L. Perkins,Kai Fu,Lynette Smith,James Lynch,Louis M. Staudt,Lisa M. Rimsza,Elaine Jaffe,Andreas Rosenwald,German K. Ott,Jan Delabie,Elias Campo,Randy D. Gascoyne,Mitchell S. Cairo,Dennis D. Weisenburger,Timothy C. Greiner,Thomas G. Gross,Wing C. Chan

View Articletitled, Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

Supplemental data

Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas

Pankaj Gupta,David M. Goldenberg,Edmund A. Rossi,Thomas M. Cardillo,John C. Byrd,Natarajan Muthusamy,Richard R. Furman,Chien-Hsing Chang

View Articletitled, Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas

Supplemental data

Myeloid Neoplasia

Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
Clinical Trials & Observations

Jessica A. Pollard,Todd A. Alonzo,Michael Loken,Robert B. Gerbing,Phoenix A. Ho,Irwin D. Bernstein,Susana C. Raimondi,Betsy Hirsch,Janet Franklin,Roland B. Walter,Alan Gamis,Soheil Meshinchi

View Articletitled, Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML

Efficacy of vorinostat in a murine model of polycythemia vera

Hajime Akada,Saeko Akada,Ajeet Gajra,Alicia Bair,Stephen Graziano,Robert E. Hutchison,Golam Mohi

View Articletitled, Efficacy of vorinostat in a murine model of polycythemia vera

Supplemental data

Phagocytes, Granulocytes, and Myelopoiesis

Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes

Tanya M. Laidlaw,Molly S. Kidder,Neil Bhattacharyya,Wei Xing,Shiliang Shen,Ginger L. Milne,Mariana C. Castells,Heng Chhay,Joshua A. Boyce

View Articletitled, Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes

Supplemental data

Platelets and Thrombopoiesis

Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets

Kristina Gegenbauer,Giuliano Elia,Alfonso Blanco-Fernandez,Albert Smolenski

View Articletitled, Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets

Red Cells, Iron, and Erythropoiesis

Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait

Lauren Gong,Catherine Maiteki-Sebuguzi,Philip J. Rosenthal,Alan E. Hubbard,Chris J. Drakeley,Grant Dorsey,Bryan Greenhouse

View Articletitled, Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait

Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry
Clinical Trials & Observations

Adrianna Vlachos,Philip S. Rosenberg,Eva Atsidaftos,Blanche P. Alter,Jeffrey M. Lipton

View Articletitled, Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry

The hypersensitive sites of the murine β-globin locus control region act independently to affect nuclear localization and transcriptional elongation

M. A. Bender,Tobias Ragoczy,Jongjoo Lee,Rachel Byron,Agnes Telling,Ann Dean,Mark Groudine

View Articletitled, The hypersensitive sites of the murine β-globin locus control region act independently to affect nuclear localization and transcriptional elongation

Supplemental data

Thrombosis and Hemostasis

The macrophage mannose receptor promotes uptake of ADAMTS13 by dendritic cells

Nicoletta Sorvillo,Wouter Pos,Linda M. van den Berg,Rob Fijnheer,Luisa Martinez-Pomares,Teunis B. Geijtenbeek,Eszter Herczenik,Jan Voorberg

View Articletitled, The macrophage mannose receptor promotes uptake of ADAMTS13 by dendritic cells

Supplemental data

Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

Cui Jian,Juan Xiao,Lingjie Gong,Christopher G. Skipwith,Sheng-Yu Jin,Hau C. Kwaan,X. Long Zheng

View Articletitled, Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

Supplemental data

Transplantation

Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic–derived antigen-presenting cells

Tomomi Toubai,Isao Tawara,Yaping Sun,Chen Liu,Evelyn Nieves,Rebecca Evers,Thea Friedman,Robert Korngold,Pavan Reddy

View Articletitled, Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic–derived antigen-presenting cells

Supplemental data

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

John E. Levine,Brent R. Logan,Juan Wu,Amin M. Alousi,Javier Bolaños-Meade,James L. M. Ferrara,Vincent T. Ho,Daniel J. Weisdorf,Sophie Paczesny

View Articletitled, Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

Supplemental data

Correspondence

Risk of second cancers in chronic myeloproliferative neoplasms

Maria Chiara Susini,Giovanna Masala,Elisabetta Antonioli,Lisa Pieri,Paola Guglielmelli,Domenico Palli,Alberto Bosi,Alessandro M. Vannucchi

View Articletitled, Risk of second cancers in chronic myeloproliferative neoplasms

Response: cancer risk in chronic myeloproliferative neoplasms

Henrik Frederiksen,Dóra Körmendiné Farkas,Christian Fynbo Christiansen,Hans Carl Hasselbalch,Henrik Toft Sørensen

View Articletitled, Response: cancer risk in chronic myeloproliferative neoplasms

Regulation of human dendritic cells by B cells depends on the signals they receive

Mohan S. Maddur,Srini V. Kaveri,Jagadeesh Bayry

View Articletitled, Regulation of human dendritic cells by B cells depends on the signals they receive

Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL

Kim De Keersmaecker,Lucienne Michaux,André Bosly,Carlos Graux,Julio Finalet Ferreiro,Peter Vandenberghe,Jan Cools,Iwona Wlodarska

View Articletitled, Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL

Persistently high quality of life conferred by coexisting congenital deficiency of terminal complement C9 in a paroxysmal nocturnal hemoglobinuria patient

Nobuyoshi Hanaoka,Yoshiko Murakami,Masahide Nagata,Shoichi Nagakura,Yuji Yonemura,Takashi Sonoki,Taroh Kinoshita,Hideki Nakakuma

View Articletitled, Persistently high quality of life conferred by coexisting congenital deficiency of terminal complement C9 in a paroxysmal nocturnal hemoglobinuria patient

Cover Image

Cover Image

In the image, a 19-day human yolk sac is shown, stained with anti–angiotensin-converting enzyme (ACE; green) and anti-CD34 (red) antibodies. ACE identifies the hemangioblastic structure (blood island) present in the mesoderm, as well as several endothelial cells bordering the newly developing blood vessels. See the article by Sinka et al on page 3712.
Front Matter
Table of Contents
Back Matter
Advertising
Editorial Board

All Issues

Advertisement intended for health care professionals

Email alerts

First Edition Alert

Latest Issue Alert

Latest
Most Read
Most Cited

Licking the wound with procoagulant vesicles

Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study

CAR T-cells in autoimmunity: game changer or stepping stone?

Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH

How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Issue Archive

Table of Contents

Inside Blood

Blood Work

Perspectives

Review Article

Clinical Trials and Observations

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure Clinical Trials & Observations

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies Clinical Trials & Observations

Hematopoiesis and Stem Cells

Immunobiology

Lymphoid Neoplasia

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study Clinical Trials & Observations

Myeloid Neoplasia

Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML Clinical Trials & Observations

Phagocytes, Granulocytes, and Myelopoiesis

Platelets and Thrombopoiesis

Red Cells, Iron, and Erythropoiesis

Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry Clinical Trials & Observations

Thrombosis and Hemostasis

Transplantation

Correspondence

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure
Clinical Trials & Observations

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
Clinical Trials & Observations

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study
Clinical Trials & Observations

Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
Clinical Trials & Observations

Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry
Clinical Trials & Observations